NCT05685095

Brief Summary

The aim of this randomized controlled pilot trial is to assess the impact of different gait rehabilitation programs on the level of physical activity and gait in daily life in patients with Parkinson's disease (PD). Two groups of 25 patients with PD will benefit from one of two gait training programs (treadmill vs. nordic walking), 3 times a week for 12 weeks. Activity level and number of steps will be remotely recorded over 7 days before, at the end, 3 and 6 months after the end of the program. Quality of life will be recorded at each time point. The impact of the gait programs on the patients' level of daily activity will be examined, comparing the changes brought about by the two programs, taking into account the modulating influence of age and cognitive function. Gait under conditions of daily life will be compared to gait parameters collected in the laboratory.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
5mo left

Started Feb 2023

Longer than P75 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Feb 2023Oct 2026

First Submitted

Initial submission to the registry

September 1, 2022

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 13, 2023

Completed
19 days until next milestone

Study Start

First participant enrolled

February 1, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2025

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Expected
Last Updated

April 6, 2023

Status Verified

April 1, 2023

Enrollment Period

2 years

First QC Date

September 1, 2022

Last Update Submit

April 3, 2023

Conditions

Keywords

adapted physical activitygaitquality of lifeactimetryParkinson's disease

Outcome Measures

Primary Outcomes (1)

  • Changes in daily energy expenditure

    Evolution over time of the daily energy expenditure together with number of steps, as recorded using an actimeter worn at the belt.

    recording 7 days in a row, at 3 months, 6 months and 9 months.

Secondary Outcomes (5)

  • Evolution of gait parameters

    3 months, 6 months and 9 months.

  • Evolution of exercise functional capacity

    3 months, 6 months and 9 months.

  • Evolution over time of the Parkinson's Disease Questionnaire-39 scale score.

    3 months, 6 months and 9 months.

  • Evolution over time of the Parkinsons' Disease Fatigue Scale score.

    3 months, 6 months and 9 months.

  • Adherence to the training program

    3 months

Study Arms (2)

Treadmill walking

EXPERIMENTAL

The training program will last 12 weeks and consist of treadmill walking. The duration of the walking bouts (and pauses), and the speed of the belt will be adjusted as needed following the patients' progress. Music will be added as suited to boost motivation and support regular cadence. All training sessions will be supervised.

Behavioral: Physical training

Nordic walking

EXPERIMENTAL

The training program will last 12 weeks and consist of Nordic walking, taught and supervised by an adapted physical activity teacher. The session will be carried out outside, weather permitting. When possible, training will gather 2 to 4 patients for group emulation. The duration of the walking bouts (and pauses) will be adjusted to follow the patients' progress.

Behavioral: Physical training

Interventions

Supervised gait training program 3 times a week, 12 weeks

Nordic walkingTreadmill walking

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Parkinson's disease, diagnosed for at least 2 years,
  • Medical treatment (if any) unchanged in the past 4 weeks at least
  • Hoehn \& Yahr score \< 3
  • Montreal cognitive assessment (MOCA) score between 20 and 30
  • Able to understand the aim and methods of the study and provide signed informed consent-

You may not qualify if:

  • Atypical parkinsonian syndrome
  • Cardiovascular pathology preventing moderate physical exercise
  • Orthostatic hypotension
  • Any condition (other than PD) interfering with gait
  • pregnant or nursing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Grenoble Alpes

Grenoble, 38043, France

Location

MeSH Terms

Conditions

Parkinson Disease

Interventions

Physical Conditioning, Human

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

ExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Moro Elena, MD PhD

    Grenoble Alpes University Hospital

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The researchers involved in data collection and in data analysis will be blinded with regard to the patients' group allocation. Randomization will be performed by an operator not otherwise involved in the study, under the RED-Cap application.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 1, 2022

First Posted

January 13, 2023

Study Start

February 1, 2023

Primary Completion

February 1, 2025

Study Completion (Estimated)

October 1, 2026

Last Updated

April 6, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations